Literature DB >> 25913345

Non-communicable diseases in an older, aging population: a developing country perspective (Jamaica).

K Mitchell-Fearon, N Waldron, H Laws, K James, D Holder-Nevins, D Willie-Tyndale, D Eldemire-Shearer.   

Abstract

UNLABELLED: Changes in the non-communicable disease (NCD) profile of older adults living in a rapidly-aging, developing country are described.
METHODS: Data from a 2012 nationally representative survey of 2,943 older adults were used to determine the burden of NCDs important to elder health. Additionally, the percentage change in NCD prevalence over a 23-year period (1989-2012) was determined.
RESULTS: In 2012, approximately 75.3% of the sample reported at least one NCD; 47.5% reported comorbidities. High blood pressure (61%), arthritis (35%) and diabetes (26%) were the most reported conditions, peaking in the 70-79 age group. Females reported higher rates of disease than males. Significant increases in prevalence occurred for all conditions except arthritis; the most significant were in diabetes (157%) and cancer (118%).
CONCLUSION: Rapid increases in NCDs are of great public health importance. Strengthening of primary health care and improvements in human resources must occur if the well-being of older adults is to be improved.

Entities:  

Mesh:

Year:  2015        PMID: 25913345     DOI: 10.1353/hpu.2015.0041

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  2 in total

1.  Strategies for Managing the Costs of Chronic Illness in the Context of Limited Financial Resources: A Qualitative Study in Dominican Persons With Arthritis.

Authors:  Julia Nascimben; Caroline Cubbison; Emma C Lape; Jeffrey N Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-08-13       Impact factor: 4.794

2.  Knowledge, Beliefs and Practices of Patients with Diabetic Retinopathy at the University Hospital of the West Indies, Jamaica.

Authors:  Tecah Foster; Lizette Mowatt; Jasneth Mullings
Journal:  J Community Health       Date:  2016-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.